<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>[REDACTED], MAY Progress Note</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Assessment</a></li><li><a href="#id2">Allergies and Adverse Reactions</a></li><li><a href="#id3">Plan</a></li><li><a href="#id4">Reason for Visit</a></li><li><a href="#id5">Encounters</a></li><li><a href="#id6">Immunizations</a></li><li><a href="#id7">Diagnostic Results</a></li><li><a href="#id8">Medications</a></li><li><a href="#id9">Problems</a></li><li><a href="#id10">Vital Signs</a></li><li><a href="#id11">Notes Section</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Assessment</a></h3><div>See Clinical Notes section</div><h3><a name="id2" href="#toc">Allergies and Adverse Reactions</a></h3><div><table>
    <thead>
        <tr>
                            <th>Medication/Group Name</th>
                <th>Reaction</th>
                <th>Severity</th>
                <th>Date</th>
        </tr>
    </thead>
    <tbody>
                <tr ID="AlertOBS-1000">
                            <td>Centrum</td>
                            <td>Unknown</td>
                            <td/>
                            <td>[REDACTED]</td>
                </tr>
                <tr ID="AlertOBS-1001">
                            <td>Iodine Containing Multivitamin</td>
                            <td>Unknown</td>
                            <td/>
                            <td>[REDACTED]</td>
                </tr>
                <tr ID="AlertOBS-1002">
                            <td>Iron Analogues</td>
                            <td>Unknown</td>
                            <td/>
                            <td>[REDACTED]</td>
                </tr>
                <tr ID="AlertOBS-1003">
                            <td>Ascorbic Acid (Vitamin C)</td>
                            <td>Unknown</td>
                            <td/>
                            <td>[REDACTED]</td>
                </tr>
    </tbody>
</table>
</div><h3><a name="id3" href="#toc">Plan</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="CarePlanRef-1004">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>LAB 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1005">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>LAB 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1006">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1007">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>INJECTION 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1008">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>PBR 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1009">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1010">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>LAB 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1011">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>PBR 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1012">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1013">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>PBR 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1014">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>LAB 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1015">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1016">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>LAB 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1017">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1018">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 30 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1019">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1020">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>DEXA scan</td>
				</tr>
				<tr ID="CarePlanRef-1021">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>CMP</td>
				</tr>
				<tr ID="CarePlanRef-1022">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>CA 27-29 panel</td>
				</tr>
				<tr ID="CarePlanRef-1023">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>CBC w/ auto diff</td>
				</tr>
				<tr ID="CarePlanRef-1024">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>Vitamin D, 25-OH, D3 panel</td>
				</tr>
				<tr ID="CarePlanRef-1025">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>CT chest/abdomen/pelvis w/ &amp; w/o contrast</td>
				</tr>
				<tr ID="CarePlanRef-1026">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>Bone scan, total body</td>
				</tr>
				<tr ID="CarePlanRef-1027">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>CA 27-29 panel</td>
				</tr>
				<tr ID="CarePlanRef-1028">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>CMP</td>
				</tr>
				<tr ID="CarePlanRef-1029">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>CBC w/ auto diff</td>
				</tr>
				<tr ID="CarePlanRef-1030">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>CA 27-29 panel</td>
				</tr>
				<tr ID="CarePlanRef-1031">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>Vitamin D, 25-OH, D3 panel</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id4" href="#toc">Reason for Visit</a></h3><div>INJECTION 15 MIN</div><h3><a name="id5" href="#toc">Encounters</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="EncounterDiagnosisRef-1032">
							<td>[REDACTED]</td>
							<td>Osteoporosis (disorder)</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1033">
							<td>[REDACTED]</td>
							<td>Primary malignant neoplasm of female breast (disorder)</td>						
					</tr>
	</tbody>
</table>
</div><h3><a name="id6" href="#toc">Immunizations</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Instructions</th>
				<th>Refusal Reason</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="ImmunizationOBS-1034">
							<td>[REDACTED]</td>
							<td>Covid-19 vaccine (Pfizer) </td>
							<td/>
							<td/>							
							<td/>							
							<td/>
							<td>Completed</td>
					</tr>
	</tbody>
</table>
</div><h3><a name="id7" href="#toc">Diagnostic Results</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Test</th>
				<th>Units</th>
				<th>Lower Limit</th>
				<th>Upper Limit</th>
				<th>Result</th>
				<th>Flag</th>
				<th>Comments</th>
				<th>Status</th>
				<th>Ordered By</th>
				<th>Specimen Source</th>
				<th>Lab Address</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ResultOBS-1035">
						<td>[REDACTED]</td>
						<td/>
						<td>Dexa, Axial Skeleton</td>
						<td/>
						<td/>
						<td/>
						<td>
          [REDACTED] Diagnostic Medical Imaging

   Patient:  [REDACTED]     Physician:  [REDACTED]
   SDMI #:  732433.0            Dr. Fax:  [REDACTED]
   Pt. DOB:  [REDACTED]         Dr. Phone:  [REDACTED]
   Pt. Sex:  Female             Dr. Addr.:  [REDACTED][REDACTED][REDACTED]
   Date of Service:  [REDACTED]   Cc:
   SDMI Location:  AN           Cc:


   DEXA SCAN


   CLINICAL HISTORY:
   [REDACTED] female with history of breast cancer, on calcium, low bone
   mass, vitamin D.


   TECHNIQUE:

   The patient was scanned on a GE Lunar Prodigy utilizing Encore Software
   ver.18. Four lumbar vertebral bodies were sampled from L1 through L4.
   The proximal left femur and proximal right femur were sampled.


   COMPARISON:

   [REDACTED]


   FINDINGS:

   PA Lumbar spine. BMD: 0.883  g/cm2. T-score: -2.5. Z-score: -1.4.
   Compared to the previous study, there has been no significant change.

   Left femoral neck. BMD: 0.860  g/cm2. T-score: -1.3. Z-score: -0.1.
    Compared to the previous study, there has been no significant change.

   Right femoral neck. BMD: 0.836  g/cm2. T-score: -1.5. Z-score: -0.3.
   Compared to the previous study, there has been a -4.0% change in BMD of
   the right total proximal femur.

   Interval change &lt; 5% may not be statistically significant.

   BMD = Bone mineral density. SD = Standard Deviation.

   World Health Organization bone density categories are: Normal = T-score
   at or above -1.0 SD; low bone mass or osteopenia = T-score between -1.0
   and -2.5 SD; osteoporosis = T-score at or below -2.5 SD. No standard
   criteria exist to diagnose osteoporosis for men or children. In males
   age [REDACTED] and older, T-scores are used to approximate
   osteopenia/osteoporosis. In children, males younger than [REDACTED],
   and premenopausal females, Z-scores are used. Z-score of -2.0 or lower
   is defined as "below the expected range for age" and Z-score above -2.0
   is "within the expected range for age." For the hip, per ISCD
   guidelines, the region with lower T-score (when choosing between
   femoral neck and total proximal femur) is used for bone mineral density
   categorization. For comparison to prior studies, per ISCD guidelines,
   the total proximal femur is preferred over the femoral neck.

   T-scores are based on a young adult, white female reference population.
   Z-scores are matched for age and gender.


   IMPRESSION:

   1. Osteoporosis.
   2. Compared to the prior examination, the bone mineral density has
   decreased in the right total hip.

   FRAX ASSESSMENT

   10-YEAR PROBABILITY OF FRACTURE
   (Based on Neck Right BMD).
   Major Osteoporotic Fracture (spine, forearm, hip or shoulder): 3.6 %
   Hip Fracture: 0.3 %
   Population: [REDACTED] (Asian)
   Risk Factors: None

   FRAX Version 4.1

   Interpreted by: [REDACTED] MD     [REDACTED] 11:23 AM






   Electronically approved by: [REDACTED]: [REDACTED] 11:28

   Online images are available for this report at www.sdmi-lv.com.</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td/>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1036">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>WBC</td>
						<td>K/uL</td>
						<td>5.3</td>
						<td>12.2</td>
						<td>5.2</td>
						<td>Low</td>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1037">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>RBC</td>
						<td>M/uL</td>
						<td>4.0</td>
						<td>5.5</td>
						<td>4.40</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1038">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>HGB</td>
						<td>g/dL</td>
						<td>11.0</td>
						<td>15.5</td>
						<td>13.2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1039">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>HCT</td>
						<td>%</td>
						<td>33.0</td>
						<td>48.0</td>
						<td>40.9</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1040">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MCV</td>
						<td>fL</td>
						<td>77.0</td>
						<td>95.0</td>
						<td>93</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1041">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MCH</td>
						<td>pg</td>
						<td>26.0</td>
						<td>33.0</td>
						<td>30</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED] 890520000  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1042">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MCHC</td>
						<td>g/dL</td>
						<td>32.0</td>
						<td>36.0</td>
						<td>32.3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1043">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>RDW</td>
						<td>%</td>
						<td>10.0</td>
						<td>15.0</td>
						<td>12.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED] 890520000  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1044">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>PLT</td>
						<td>10e3/uL</td>
						<td>150.0</td>
						<td>450.0</td>
						<td>316</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1045">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>Neu %</td>
						<td>%</td>
						<td>42.0</td>
						<td>71.0</td>
						<td>49</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1046">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>LY %</td>
						<td>%</td>
						<td>24.0</td>
						<td>44.0</td>
						<td>42</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1047">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MO %</td>
						<td>%</td>
						<td>2.0</td>
						<td>12.0</td>
						<td>6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED] 890520000  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1048">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>EO %</td>
						<td>%</td>
						<td>0.0</td>
						<td>8.0</td>
						<td>2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1049">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>BA %</td>
						<td>%</td>
						<td>0.0</td>
						<td>3.0</td>
						<td>1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1050">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>Neu # (ANC)</td>
						<td>K/uL</td>
						<td>2.4</td>
						<td>5.2</td>
						<td>2.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1051">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>LY #</td>
						<td>K/uL</td>
						<td>1.5</td>
						<td>3.7</td>
						<td>2.2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1052">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MO #</td>
						<td>K/uL</td>
						<td>0.4</td>
						<td>1.2</td>
						<td>0.3</td>
						<td>Low</td>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1053">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>EO #</td>
						<td>10e3/uL</td>
						<td>0.0</td>
						<td>0.2</td>
						<td>0.09</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1054">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>BA #</td>
						<td>K/uL</td>
						<td>0.0</td>
						<td>0.1</td>
						<td>0.1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1055">
						<td>[REDACTED]</td>
						<td>CA 27-29 panel</td>
						<td>CA 27-29</td>
						<td>U/mL</td>
						<td>0.0</td>
						<td>38.6</td>
						<td>50.9</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1056">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Glucose</td>
						<td>mg/dL</td>
						<td>74.0</td>
						<td>106.0</td>
						<td>136</td>
						<td>High</td>
						<td>High</td>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1057">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>BUN</td>
						<td>mg/dL</td>
						<td>7.0</td>
						<td>25.0</td>
						<td>13</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1058">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Creatinine</td>
						<td>mg/dL</td>
						<td>0.6</td>
						<td>1.3</td>
						<td>0.7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1059">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Calcium</td>
						<td>mg/dL</td>
						<td>8.7</td>
						<td>10.4</td>
						<td>9.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1060">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Total protein</td>
						<td>g/dL</td>
						<td>5.7</td>
						<td>8.2</td>
						<td>7.4</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1061">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Alkaline phosphatase</td>
						<td>U/L</td>
						<td>45.0</td>
						<td>129.0</td>
						<td>63</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1062">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>ALT/SGPT</td>
						<td>U/L</td>
						<td>10.0</td>
						<td>49.0</td>
						<td>17</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1063">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>AST/SGOT</td>
						<td>U/L</td>
						<td>3.0</td>
						<td>34.0</td>
						<td>22</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1064">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Sodium, mEq/L</td>
						<td>meq/L</td>
						<td>136.0</td>
						<td>145.0</td>
						<td>140</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1065">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Potassium</td>
						<td>mmol/L</td>
						<td>3.4</td>
						<td>5.1</td>
						<td>3.9</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1066">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Chloride, mEq/L</td>
						<td>meq/L</td>
						<td>98.0</td>
						<td>107.0</td>
						<td>101</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1067">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>CO2 content</td>
						<td>meq/L</td>
						<td>20.0</td>
						<td>31.0</td>
						<td>31</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1068">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>GFR estimate</td>
						<td>ml/min/1.73m2</td>
						<td/>
						<td/>
						<td>99</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1069">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>GFR African American, estimated</td>
						<td>ml/min/1.73m2</td>
						<td/>
						<td/>
						<td>120</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1070">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Albumin</td>
						<td>g/dL</td>
						<td>3.2</td>
						<td>4.8</td>
						<td>4.7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1071">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Bilirubin, total</td>
						<td>mg/dL</td>
						<td>0.3</td>
						<td>1.2</td>
						<td>0.9</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1072">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>A/G ratio</td>
						<td>%</td>
						<td>0.9</td>
						<td>1.9</td>
						<td>1.8</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1073">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Globulin</td>
						<td>g/dL</td>
						<td>2.5</td>
						<td>3.4</td>
						<td>2.68</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1074">
						<td>[REDACTED]</td>
						<td>Vitamin D, 25-OH, D3 panel</td>
						<td>Vitamin D, 25-hydroxy</td>
						<td>ng/ml</td>
						<td>30.0</td>
						<td>100.0</td>
						<td>57</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1075">
						<td>[REDACTED]</td>
						<td/>
						<td>Ct Abdo,Pelv,Chest W/wout</td>
						<td/>
						<td/>
						<td/>
						<td>
          [REDACTED] Diagnostic Medical Imaging

   Patient:  May Roces          Physician:  [REDACTED]
   SDMI #:  732433.0            Dr. Fax:  [REDACTED]
   Pt. DOB:  [REDACTED]         Dr. Phone:  [REDACTED]
   Pt. Sex:  Female             Dr. Addr.:  [REDACTED][REDACTED][REDACTED]
   Date of Service:  [REDACTED]   Cc:
   SDMI Location:  AN           Cc:


   CT CHEST WITH AND WITHOUT


   CLINICAL HISTORY:

   Breast cancer


   TECHNIQUE:

   CT of the chest was obtained with and without intravenous contrast.
   Coronal and sagittal reconstruction was also obtained. Contiguous 2 mm
   axial images. 60 cc of GE Omni 350 contrast administered from a 500 cc
   bottle.

   CT dose reduction technique: Automated Exposure Control
   Total CT Dose Length Product (DLP): 344.60 mGy.cm


   COMPARISON:

   PET/CT [REDACTED]


   FINDINGS:

   There is mild atelectasis and scarring in the lung bases. No suspicious
   pulmonary nodules or masses. No effusions or pneumothoraces.
   [REDACTED] is within normal limits without lymphadenopathy. No
   axillary lymphadenopathy. There are mild degenerative changes in the
   spine.


   IMPRESSION:

   No evidence of metastatic disease to the chest.


   CT ABDOMEN WITH AND WITHOUT


   CLINICAL HISTORY:

   Breast cancer


   TECHNIQUE:

   CT abdomen performed with and without IV contrast and without oral
   contrast reviewed by contiguous 5 mm axial images. Coronal and sagittal
   reconstruction was also obtained. 60
   cc of GE Omni 350 contrast administered from a 500 cc bottle.

   CT dose reduction technique: Automated Exposure Control
   Total CT Dose Length Product (DLP): 344.60 mGy.cm


   COMPARISON:

   PET/CT [REDACTED]


   FINDINGS:

   The liver, gallbladder, pancreas, kidneys, adrenal glands, and spleen
   appear normal. No free fluid or free air. The visualized small and
   large bowel appear normal in size and caliber. There is levoscoliosis
   of the lumbar spine with associated multilevel degenerative disease
   including grade 1 anterolisthesis of L5 on S1.


   IMPRESSION:

   No evidence of metastatic disease to the abdomen.



   CT PELVIS WITH AND WITHOUT


   CLINICAL HISTORY:

   Breast cancer


   TECHNIQUE:

   CT pelvis performed with and without IV contrast and without oral
   contrast reviewed by contiguous 5 mm axial images. Coronal and sagittal
   reconstruction was also obtained. 60 cc of GE Omni 350 contrast
   administered from a 500 cc bottle.

   CT dose reduction technique: Automated Exposure Control
   Total CT Dose Length Product (DLP): 344.60 mGy.cm


   COMPARISON:

   PET/CT [REDACTED]


   FINDINGS:

   Small and large bowels are of normal-caliber. A normal-appearing
   appendix is identified. Uterus and ovaries appear unremarkable. Bladder
   appears unremarkable. No lymphadenopathy. No free fluid. The bony
   pelvis is intact.


   IMPRESSION:

   No evidence of metastatic disease to the pelvis.

   Interpreted by: [REDACTED] MD        [REDACTED]  9:39 AM






   Electronically approved by: [REDACTED] MD     Date: [REDACTED] 09:59

   Online images are available for this report at www.sdmi-lv.com.</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td/>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1076">
						<td>[REDACTED]</td>
						<td>CA 27-29 panel</td>
						<td>CA 27-29</td>
						<td>U/mL</td>
						<td>0.0</td>
						<td>38.6</td>
						<td>45.0</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>[REDACTED], [REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1077">
						<td>[REDACTED]</td>
						<td>CA 27-29 panel</td>
						<td>CA 27-29</td>
						<td>U/mL</td>
						<td/>
						<td/>
						<td>48</td>
						<td>High</td>
						<td>This test was performed using the Siemens
Chemiluminescent method. Values obtained from
different assay methods cannot be used
interchangeably. CA 27.29 levels, regardless of
value, should not be interpreted as absolute
evidence of the presence or absence of disease.
</td>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1078">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Glucose, fasting</td>
						<td>mg/dL</td>
						<td>65.0</td>
						<td>99.0</td>
						<td>89</td>
						<td/>
						<td>           Fasting reference interval
</td>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1079">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>BUN</td>
						<td>mg/dL</td>
						<td>7.0</td>
						<td>25.0</td>
						<td>10</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1080">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Creatinine</td>
						<td>mg/dL</td>
						<td>0.5</td>
						<td>1.03</td>
						<td>0.53</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1081">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>eGFR, mL/min/1.73</td>
						<td>mL/min/1.73m2</td>
						<td/>
						<td/>
						<td>106</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1082">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>BUN/Creatinine ratio</td>
						<td>(calc)</td>
						<td>6.0</td>
						<td>22.0</td>
						<td>SEE NOTE:</td>
						<td/>
						<td>   Not Reported: BUN and Creatinine are within
   reference range.
</td>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1083">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Sodium</td>
						<td>mmol/L</td>
						<td>135.0</td>
						<td>146.0</td>
						<td>136</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1084">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Potassium</td>
						<td>mmol/L</td>
						<td>3.5</td>
						<td>5.3</td>
						<td>4.1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1085">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Chloride</td>
						<td>mmol/L</td>
						<td>98.0</td>
						<td>110.0</td>
						<td>101</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1086">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>CO2</td>
						<td>mmol/L</td>
						<td>20.0</td>
						<td>32.0</td>
						<td>26</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1087">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Calcium</td>
						<td>mg/dL</td>
						<td>8.6</td>
						<td>10.4</td>
						<td>9.0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1088">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Total protein</td>
						<td>g/dL</td>
						<td>6.1</td>
						<td>8.1</td>
						<td>7.0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1089">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Albumin</td>
						<td>g/dL</td>
						<td>3.6</td>
						<td>5.1</td>
						<td>4.4</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1090">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Globulin</td>
						<td>g/dL(calc)</td>
						<td>1.9</td>
						<td>3.7</td>
						<td>2.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1091">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>A/G ratio</td>
						<td>(calc)</td>
						<td>1.0</td>
						<td>2.5</td>
						<td>1.7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1092">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Bilirubin, total</td>
						<td>mg/dL</td>
						<td>0.2</td>
						<td>1.2</td>
						<td>0.9</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1093">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>Alkaline phosphatase</td>
						<td>U/L</td>
						<td>37.0</td>
						<td>153.0</td>
						<td>40</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1094">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>AST/SGOT</td>
						<td>U/L</td>
						<td>10.0</td>
						<td>35.0</td>
						<td>24</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1095">
						<td>[REDACTED]</td>
						<td>CMP</td>
						<td>ALT/SGPT</td>
						<td>U/L</td>
						<td>6.0</td>
						<td>29.0</td>
						<td>16</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1096">
						<td>[REDACTED]</td>
						<td>Vitamin D, 25-OH, D3 panel</td>
						<td>Vitamin D, 25-hydroxy</td>
						<td>ng/mL</td>
						<td>30.0</td>
						<td>100.0</td>
						<td>50</td>
						<td/>
						<td>Vitamin D Status         25-OH Vitamin D:

Deficiency:                    &lt;20 ng/mL
Insufficiency:             20 - 29 ng/mL
Optimal:                 &gt; or = 30 ng/mL

For 25-OH Vitamin D testing on patients on
D2-supplementation and patients for whom quantitation
of D2 and D3 fractions is required, the QuestAssureD(TM)
25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order
code 92888 (patients &gt;2yrs).

See Note 1

Note 1

For additional information, please refer to
http://education.QuestDiagnostics.com/faq/FAQ199
(This link is being provided for informational/
educational purposes only.)</td>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>SER</td>
                        <td>QUEST, [REDACTED][REDACTED]  </td>
				</tr>
				<tr ID="ResultOBS-1097">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>LY %</td>
						<td>%</td>
						<td>24.0</td>
						<td>44.0</td>
						<td>34</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1098">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MO %</td>
						<td>%</td>
						<td>2.0</td>
						<td>12.0</td>
						<td>7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1099">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>EO %</td>
						<td>%</td>
						<td>0.0</td>
						<td>8.0</td>
						<td>2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1100">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>BA %</td>
						<td>%</td>
						<td>0.0</td>
						<td>3.0</td>
						<td>1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1101">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>Neu # (ANC)</td>
						<td>K/uL</td>
						<td>2.4</td>
						<td>5.2</td>
						<td>2.7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1102">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>LY #</td>
						<td>K/uL</td>
						<td>1.5</td>
						<td>3.7</td>
						<td>1.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1103">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MO #</td>
						<td>K/uL</td>
						<td>0.4</td>
						<td>1.2</td>
						<td>0.3</td>
						<td>Low</td>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1104">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>EO #</td>
						<td>10e3/uL</td>
						<td>0.0</td>
						<td>0.2</td>
						<td>0.11</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1105">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>BA #</td>
						<td>K/uL</td>
						<td>0.0</td>
						<td>0.1</td>
						<td>0.0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1106">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>WBC</td>
						<td>K/uL</td>
						<td>5.3</td>
						<td>12.2</td>
						<td>4.8</td>
						<td>Low</td>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1107">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>RBC</td>
						<td>M/uL</td>
						<td>4.0</td>
						<td>5.5</td>
						<td>4.10</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1108">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>HGB</td>
						<td>g/dL</td>
						<td>11.0</td>
						<td>15.5</td>
						<td>12.8</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1109">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>HCT</td>
						<td>%</td>
						<td>33.0</td>
						<td>48.0</td>
						<td>38.3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1110">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MCV</td>
						<td>fL</td>
						<td>77.0</td>
						<td>95.0</td>
						<td>93</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1111">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MCH</td>
						<td>pg</td>
						<td>26.0</td>
						<td>33.0</td>
						<td>31</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1112">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>MCHC</td>
						<td>g/dL</td>
						<td>32.0</td>
						<td>36.0</td>
						<td>33.4</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1113">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>RDW</td>
						<td>%</td>
						<td>10.0</td>
						<td>15.0</td>
						<td>12.5</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED] 890520000  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1114">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>PLT</td>
						<td>10e3/uL</td>
						<td>150.0</td>
						<td>450.0</td>
						<td>281</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED]  [REDACTED] </td>
				</tr>
				<tr ID="ResultOBS-1115">
						<td>[REDACTED]</td>
						<td>CBC w/ auto diff</td>
						<td>Neu %</td>
						<td>%</td>
						<td>42.0</td>
						<td>71.0</td>
						<td>56</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td>WB</td>
                        <td>HORIZON, [REDACTED][REDACTED] 890520000  [REDACTED] </td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id8" href="#toc">Medications</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Frequency</th>
				<th>Instructions</th>
				<th>Start Date</th>
				<th>End Date</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="MedicationOBS-1116">
							<td>[REDACTED]</td>
							<td>1 ML denosumab 60 MG/ML Prefilled Syringe [Prolia] </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td>once</td>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1117">
							<td>[REDACTED]</td>
							<td>famotidine 10 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>20.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1118">
							<td>[REDACTED]</td>
							<td>methylprednisolone 2000 MG Injection </td>
							<td>intravenously</td>
							<td>125.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1119">
							<td>[REDACTED]</td>
							<td>diphenhydramine hydrochloride 0.5 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>50.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1120">
							<td>[REDACTED]</td>
							<td>hydrocortisone 100 MG Injection </td>
							<td>intravenously</td>
							<td>100.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1121">
							<td>[REDACTED]</td>
							<td>1 ML epinephrine 1 MG/ML Injection </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>once</td>
							<td>Re-initiate treatment only upon physician approval. </td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1122">
							<td>[REDACTED]</td>
							<td>1 ML denosumab 60 MG/ML Prefilled Syringe [Prolia] </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td>once</td>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1123">
							<td>[REDACTED]</td>
							<td>famotidine 10 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>20.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1124">
							<td>[REDACTED]</td>
							<td>methylprednisolone 2000 MG Injection </td>
							<td>intravenously</td>
							<td>125.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1125">
							<td>[REDACTED]</td>
							<td>1 ML epinephrine 1 MG/ML Injection </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>once</td>
							<td>Re-initiate treatment only upon physician approval. </td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1126">
							<td>[REDACTED]</td>
							<td>diphenhydramine hydrochloride 0.5 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>50.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1127">
							<td>[REDACTED]</td>
							<td>hydrocortisone 100 MG Injection </td>
							<td>intravenously</td>
							<td>100.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1128">
							<td>[REDACTED]</td>
							<td>famotidine 10 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>20.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1129">
							<td>[REDACTED]</td>
							<td>hydrocortisone 100 MG Injection </td>
							<td>intravenously</td>
							<td>100.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1130">
							<td>[REDACTED]</td>
							<td>methylprednisolone 2000 MG Injection </td>
							<td>intravenously</td>
							<td>125.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1131">
							<td>[REDACTED]</td>
							<td>diphenhydramine hydrochloride 0.5 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>50.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1132">
							<td>[REDACTED]</td>
							<td>1 ML epinephrine 1 MG/ML Injection </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>once</td>
							<td>Re-initiate treatment only upon physician approval. </td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1133">
							<td>[REDACTED]</td>
							<td>1 ML denosumab 60 MG/ML Prefilled Syringe [Prolia] </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td>once</td>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1134">
							<td>[REDACTED]</td>
							<td>hydrocortisone 100 MG Injection </td>
							<td>intravenously</td>
							<td>100.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1135">
							<td>[REDACTED]</td>
							<td>1 ML denosumab 60 MG/ML Prefilled Syringe [Prolia] </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td>once</td>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1136">
							<td>[REDACTED]</td>
							<td>diphenhydramine hydrochloride 0.5 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>50.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1137">
							<td>[REDACTED]</td>
							<td>famotidine 10 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>20.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1138">
							<td>[REDACTED]</td>
							<td>methylprednisolone 2000 MG Injection </td>
							<td>intravenously</td>
							<td>125.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1139">
							<td>[REDACTED]</td>
							<td>1 ML epinephrine 1 MG/ML Injection </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>once</td>
							<td>Re-initiate treatment only upon physician approval. </td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1140">
							<td>[REDACTED]</td>
							<td>hydrocortisone 100 MG Injection </td>
							<td>intravenously</td>
							<td>100.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1141">
							<td>[REDACTED]</td>
							<td>methylprednisolone 2000 MG Injection </td>
							<td>intravenously</td>
							<td>125.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1142">
							<td>[REDACTED]</td>
							<td>1 ML epinephrine 1 MG/ML Injection </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>once</td>
							<td>Re-initiate treatment only upon physician approval. </td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1143">
							<td>[REDACTED]</td>
							<td>famotidine 10 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>20.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1144">
							<td>[REDACTED]</td>
							<td>diphenhydramine hydrochloride 0.5 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>50.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1145">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1146">
							<td>[REDACTED]</td>
							<td>diphenhydramine hydrochloride 0.5 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>50.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1147">
							<td>[REDACTED]</td>
							<td>methylprednisolone 2000 MG Injection </td>
							<td>intravenously</td>
							<td>125.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1148">
							<td>[REDACTED]</td>
							<td>hydrocortisone 100 MG Injection </td>
							<td>intravenously</td>
							<td>100.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1149">
							<td>[REDACTED]</td>
							<td>famotidine 10 MG/ML Injectable Solution </td>
							<td>intravenously</td>
							<td>20.0 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1150">
							<td>[REDACTED]</td>
							<td>1 ML epinephrine 1 MG/ML Injection </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>once</td>
							<td>Re-initiate treatment only upon physician approval. </td>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1151">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1152">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1153">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1154">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1155">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>daily</td>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1156">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1157">
							<td>[REDACTED]</td>
							<td>Turmeric (Curcumin) Oral </td>
							<td>PO</td>
							<td>1.0 CAPSULE(S)</td>
							<td>daily</td>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1158">
							<td>[REDACTED]</td>
							<td>Cholecalciferol Oral </td>
							<td>PO</td>
							<td>10.0 MCG</td>
							<td>daily</td>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1159">
							<td>[REDACTED]</td>
							<td>Acetaminophen Oral ER Tab </td>
							<td>PO</td>
							<td>1.0 TABLET(S), SUSTAINED ACTION</td>
							<td>PRN</td>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1160">
							<td>[REDACTED]</td>
							<td>Multivitamins Oral Tablet </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1161">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1162">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1163">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1164">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1165">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1166">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1167">
							<td>[REDACTED]</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
	</tbody>
</table>
</div><h3><a name="id9" href="#toc">Problems</a></h3><div><table>
	<thead>
		<tr>
							<th>Diagnosis</th>
				<th>Status</th>
				<th>Date of Diagnosis</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ProblemOBS-1168">
						<td>Osteoporosis (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1169">
						<td>Other long-term current use of drug therapy</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1170">
						<td>Primary malignant neoplasm of female breast (disorder)</td>
						<td>Active</td>
						<td>[REDACTED]</td>
				</tr>
				<tr ID="ProblemOBS-1171">
						<td>Vitamin D deficiency (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1172">
						<td>Long-term current use of aromatase inhibitor (situation)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1173">
						<td>Cancer antigen 27-29 above reference range (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1174">
						<td>Other specified disorders of bone density and structure, other site</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1175">
						<td>Other specified anemias</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1176">
						<td>Estrogen receptor positive status [ER+]</td>
						<td>Active</td>
						<td/>
				</tr>
	</tbody>
</table>
</div><h3><a name="id10" href="#toc">Vital Signs</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="VitalSignsRef-1177">
						<td>[REDACTED]</td>
						<td>
							Heart Beat
							
						</td>
						<td>89.00</td>
				</tr>
				<tr ID="VitalSignsRef-1178">
						<td>[REDACTED]</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>16.00</td>
				</tr>
				<tr ID="VitalSignsRef-1179">
						<td>[REDACTED]</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>98.00</td>
				</tr>
				<tr ID="VitalSignsRef-1180">
						<td>[REDACTED]</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>120</td>
				</tr>
				<tr ID="VitalSignsRef-1181">
						<td>[REDACTED]</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>76</td>
				</tr>
				<tr ID="VitalSignsRef-1182">
						<td>[REDACTED]</td>
						<td>
							Body Temperature
							
						</td>
						<td>98.20</td>
				</tr>
				<tr ID="VitalSignsRef-1183">
						<td>[REDACTED]</td>
						<td>
							Weight
							
						</td>
						<td>99.60</td>
				</tr>
				<tr ID="VitalSignsRef-1184">
						<td>[REDACTED]</td>
						<td>
							Height
							
						</td>
						<td>57.50</td>
				</tr>
				<tr ID="VitalSignsRef-1185">
						<td>[REDACTED]</td>
						<td>
							BMI
							
						</td>
						<td>21.18</td>
				</tr>
				<tr ID="VitalSignsRef-1186">
						<td>[REDACTED]</td>
						<td>
							BSA
							
						</td>
						<td>1.35</td>
				</tr>
				<tr ID="VitalSignsRef-1187">
						<td>[REDACTED]</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1188">
						<td>[REDACTED]</td>
						<td>
							BSA
							
						</td>
						<td>1.35</td>
				</tr>
				<tr ID="VitalSignsRef-1189">
						<td>[REDACTED]</td>
						<td>
							BMI
							
						</td>
						<td>21.48</td>
				</tr>
				<tr ID="VitalSignsRef-1190">
						<td>[REDACTED]</td>
						<td>
							Height
							
						</td>
						<td>57.50</td>
				</tr>
				<tr ID="VitalSignsRef-1191">
						<td>[REDACTED]</td>
						<td>
							Weight
							
						</td>
						<td>101.00</td>
				</tr>
				<tr ID="VitalSignsRef-1192">
						<td>[REDACTED]</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1193">
						<td>[REDACTED]</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>124</td>
				</tr>
				<tr ID="VitalSignsRef-1194">
						<td>[REDACTED]</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>60</td>
				</tr>
				<tr ID="VitalSignsRef-1195">
						<td>[REDACTED]</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>96.00</td>
				</tr>
				<tr ID="VitalSignsRef-1196">
						<td>[REDACTED]</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>16.00</td>
				</tr>
				<tr ID="VitalSignsRef-1197">
						<td>[REDACTED]</td>
						<td>
							Body Temperature
							
						</td>
						<td>98.00</td>
				</tr>
				<tr ID="VitalSignsRef-1198">
						<td>[REDACTED]</td>
						<td>
							Heart Beat
							
						</td>
						<td>82.00</td>
				</tr>
				<tr ID="VitalSignsRef-1199">
						<td>[REDACTED]</td>
						<td>
							BMI
							
						</td>
						<td>20.67</td>
				</tr>
				<tr ID="VitalSignsRef-1200">
						<td>[REDACTED]</td>
						<td>
							BSA
							
						</td>
						<td>1.33</td>
				</tr>
				<tr ID="VitalSignsRef-1201">
						<td>[REDACTED]</td>
						<td>
							Height
							
						</td>
						<td>57.50</td>
				</tr>
				<tr ID="VitalSignsRef-1202">
						<td>[REDACTED]</td>
						<td>
							Weight
							
						</td>
						<td>97.20</td>
				</tr>
				<tr ID="VitalSignsRef-1203">
						<td>[REDACTED]</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1204">
						<td>[REDACTED]</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>122</td>
				</tr>
				<tr ID="VitalSignsRef-1205">
						<td>[REDACTED]</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>70</td>
				</tr>
				<tr ID="VitalSignsRef-1206">
						<td>[REDACTED]</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>99.00</td>
				</tr>
				<tr ID="VitalSignsRef-1207">
						<td>[REDACTED]</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>20.00</td>
				</tr>
				<tr ID="VitalSignsRef-1208">
						<td>[REDACTED]</td>
						<td>
							Heart Beat
							
						</td>
						<td>87.00</td>
				</tr>
				<tr ID="VitalSignsRef-1209">
						<td>[REDACTED]</td>
						<td>
							Body Temperature
							
						</td>
						<td>97.80</td>
				</tr>
				<tr ID="VitalSignsRef-1210">
						<td>[REDACTED]</td>
						<td>
							BSA
							
						</td>
						<td>1.32</td>
				</tr>
				<tr ID="VitalSignsRef-1211">
						<td>[REDACTED]</td>
						<td>
							BMI
							
						</td>
						<td>20.29</td>
				</tr>
				<tr ID="VitalSignsRef-1212">
						<td>[REDACTED]</td>
						<td>
							Body Temperature
							
						</td>
						<td>97.80</td>
				</tr>
				<tr ID="VitalSignsRef-1213">
						<td>[REDACTED]</td>
						<td>
							Heart Beat
							
						</td>
						<td>80.00</td>
				</tr>
				<tr ID="VitalSignsRef-1214">
						<td>[REDACTED]</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>16.00</td>
				</tr>
				<tr ID="VitalSignsRef-1215">
						<td>[REDACTED]</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>96.00</td>
				</tr>
				<tr ID="VitalSignsRef-1216">
						<td>[REDACTED]</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>134</td>
				</tr>
				<tr ID="VitalSignsRef-1217">
						<td>[REDACTED]</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>80</td>
				</tr>
				<tr ID="VitalSignsRef-1218">
						<td>[REDACTED]</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1219">
						<td>[REDACTED]</td>
						<td>
							Weight
							
						</td>
						<td>95.40</td>
				</tr>
				<tr ID="VitalSignsRef-1220">
						<td>[REDACTED]</td>
						<td>
							Height
							
						</td>
						<td>57.50</td>
				</tr>
				<tr ID="VitalSignsRef-1221">
						<td>[REDACTED]</td>
						<td>
							BSA
							
						</td>
						<td>1.32</td>
				</tr>
				<tr ID="VitalSignsRef-1222">
						<td>[REDACTED]</td>
						<td>
							Heart Beat
							
						</td>
						<td>72.00</td>
				</tr>
				<tr ID="VitalSignsRef-1223">
						<td>[REDACTED]</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>18.00</td>
				</tr>
				<tr ID="VitalSignsRef-1224">
						<td>[REDACTED]</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>96.00</td>
				</tr>
				<tr ID="VitalSignsRef-1225">
						<td>[REDACTED]</td>
						<td>
							Body Temperature
							
						</td>
						<td>98.00</td>
				</tr>
				<tr ID="VitalSignsRef-1226">
						<td>[REDACTED]</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1227">
						<td>[REDACTED]</td>
						<td>
							Weight
							
						</td>
						<td>95.00</td>
				</tr>
				<tr ID="VitalSignsRef-1228">
						<td>[REDACTED]</td>
						<td>
							Height
							
						</td>
						<td>57.50</td>
				</tr>
				<tr ID="VitalSignsRef-1229">
						<td>[REDACTED]</td>
						<td>
							BMI
							
						</td>
						<td>20.20</td>
				</tr>
				<tr ID="VitalSignsRef-1230">
						<td>[REDACTED]</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>102</td>
				</tr>
				<tr ID="VitalSignsRef-1231">
						<td>[REDACTED]</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>68</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id11" href="#toc">Notes Section</a></h3><div>	<ul><li>
		        Follow Up Note ([REDACTED]) [REDACTED]: 
		        <p>
		        		
<br/>
[REDACTED][REDACTED]<br/>
[REDACTED][REDACTED]<br/>
P: [REDACTED]  F: [REDACTED]<br/>
<br/>

<br/>
PATIENT: [REDACTED]

<br/>MRN: [REDACTED]

<br/>DATE: [REDACTED]

<br/>DOB: [REDACTED]

<br/>ATTENDING PHYSICIAN: [REDACTED], [REDACTED]

<br/>
FOLLOW-UP NOTE<br/>
<br/>
<br/>CHIEF COMPLAINT~ <br/>
Follow-up for breast cancer management (ER/PR positive, HER-2 negative)<br/>
monitoring and management of treatment-related complications from letrozole (adjuvant endocrine therapy) <br/>
<br/>


<br/>
<br/>INTERVAL HISTORY~ <br/>
Ms. [REDACTED] is here for a follow-up for the management of breast cancer (letrozole). Since the previous visit, the patient is doing well. She denies any new medical issues or concerns. I reviewed her previous PET scan results which showed no FDG avid malignancy. She continues vitamin D and glucosamine supplementation. I reviewed her laboratory studies with the patient which showed blood counts and chemistries are within normal limits. Her CA 27-29 has decreased from 32.2 to 28.8. We will continue to monitor [REDACTED]. Otherwise, she has no further concerns at this time.<br/>
<br/>
[REDACTED]:  Ms. [REDACTED] is here for her routine 6-month follow-up for continued management and surveillance for right breast cancer and continued management with letrozole.  Patient underwent bilateral mastectomy, no mammogram is indicated.  Patient has had no recent hospitalizations or illnesses.  Patient denies any unusual headaches, abdominal pain, or bone pain.  She denies any changes in bilateral anterior chest walls.  I personally reviewed her laboratory studies that were completed on [REDACTED], CMP, CBC, vitamin D are all within normal limits and unremarkable.  Cancer marker has continued to fluctuate, still within normal limits at this time, 37.6, we will continue to closely monitor.  Patient is overdue for her DEXA scan, I will order for stat scan to be completed.  She continues to take and tolerate letrozole with no adverse side effects.  She continues to follow-up with [REDACTED] routinely.  We will follow-up [REDACTED] time with labs and review DEXA scan at that time.  No other issues or concerns at this time.<br/>
<br/>
<br/>SUMMARY OF LABORATORY STUDIES~ <br/>
CBC:<br/>
([REDACTED]) WBC x 10^3/uL : 4.8 (L); RBC x 10^6/uL : 4.03; HGB g/dL : 12.3; HCT % : 37.5; MCV fL : 93; MCH pg : 31; MCHC g/dL : 32.8; RDW % : 12.4; PLT x 10^3/uL : 300; Neu % : 57; LY % : 35; MO % : 5; EO % : 2; Neu # (ANC) x 10^3/uL : 2.8; BA % : 1; MO # x 10^3/uL : 0.2 (L); EO # x 10^3/uL : 0.10; BA # x 10^3/uL : 0.0; LY # x 10^3/uL : 1.7<br/>
CMP:<br/>
([REDACTED]) Glucose mg/dL : 130 (H); BUN mg/dL : 13; Creatinine mg/dL : 0.6; Potassium mmol/L : 3.6; Sodium, mEq/L : 137; Calcium mg/dL : 9.2; [REDACTED], mEq/L : 103; Albumin g/dL : 4.4; Total protein g/dL : 6.7; Globulin g/dL : 2.30 (L); A/G ratio : 1.9; Bilirubin, total mg/dL : 0.6; Alkaline phosphatase U/L : 64; AST/SGOT U/L : 21; ALT/SGPT U/L : 17; GFR estimate mL/min/1.73m2 : 107; GFR African American, estimated mL/min/1.73m2 : 129; Vitamin D, 25-hydroxy ng/mL : 52; CO2 content mEq/L : 30<br/>
<br/>
<br/>SUMMARY OF IMAGING STUDIES~ <br/>
[REDACTED] PET with nondiagnostic CT scan: Since [REDACTED], no FDG avid malignancy. Resolved uptake and decreased size of the right level 1 axillary node, consistent with a reactive node.<br/>
[REDACTED] Right breast ultrasound: BI-RADS 2: Benign. Right mastectomy. No sonographic evidence of malignancy in the right breast or axillary lymphadenopathy.<br/>
[REDACTED] Right breast/axillary ultrasound: Stable morphologically-appearing right axillary lymph node. No new/pathologic lymphadenopathy identified.<br/>
[REDACTED] Ultrasound extremity limited: Suspicious appearing right axillary lymph node as above, given clinical history recommend ultrasound guided biopsy. If this lymph node corresponds to the lymph node identified [REDACTED], it has increased in size.<br/>
[REDACTED] PET/CT: Minimally FDG avid 0.8cm right level 1 axillary node is indeterminate. Suggest further evaluation with ultrasound.<br/>
[REDACTED] MRI breasts: BI-RADS category 6- known biopsy-proven malignancy. 2.0 x 2.0 x 1.6 cm speculated mass at the 12:00 radius consistent with known invasive ductal carcinoma. 2 cm inferior to this is a 1.2 cm satellite nodule in the central right breast consistent with additional extent of disease.<br/>
[REDACTED] mammography diagnostic bilat: Right breast BI-RADS 5: Highly suggestive of malignancy. Left breast BI-RADS 1: Negative. Recommend ultrasound-guided biopsy of the palpable right breast 12:00 mass.<br/>
[REDACTED] mammogram: asymmetrical density is slightly less conspicuous on [REDACTED] examination. No sonographic correlate is seen . Likely represents asymmetrical fibroglandular tissue. Final assessment category BI-RADS 2 benign, right breast. <br/>
[REDACTED] mammogram: indeterminate asymmetry in the right breast requires additional evaluation. Final assessment category: BIRADS 0- incomplete: needs additional imaging evaluation.<br/>
<br/>
<br/>
<br/>SUMMARY OF PATHOLOGY~ <br/>
[REDACTED] Submitted as ultrasound guided right axilla biopsy: Lymphoid tissue, favor reactive.<br/>
<ul><li>Sections show preserved nodal architecture consisting predominantly of small lymphocytes. Immunohistochemical stains are performed on block A1 and A3. CD3 and CD20 highlight normal distribution of T and B cells. No evidence for a lymphoid proliferative.</li></ul>
[REDACTED] Chest Wall Biopsy: Benign cyst with features suggestive of steatocystoma. Skin with solar elastosis and focal early seborrheic keratosis. Negative for atypia or malignancy.<br/>
[REDACTED]<br/>
Histology: Invasive ductal carcinoma<br/>
Grade: 2 of 3, moderately differentiated<br/>
Tumor location: right breast<br/>
DCIS/LCIS: Not identified<br/>
Lymphovascular invasion: Not identified<br/>
Margins: cannot be assessed<br/>
ER receptor: Positive<br/>
PR receptor: Positive<br/>
Ki-67: 51-90%<br/>
HER-2/neu: Negative<br/>
Pathologic stage: at least pT1bNX<br/>
<br/>
<br/>
<br/>FAMILY HISTORY~ <br/>
Mother has hypercholesterolemia and hypertension.<br/>
Father has a history of stroke, blood clots and Lung Cancer diagnosed at the age of [REDACTED].<br/>
Uncle has a history of diabetes.<br/>
Maternal uncle - throat cancer.<br/>
<br/>
<br/>OB/GYN HISTORY~ <br/>
Menopausal status: postmenopausal.<br/>
<br/>
<br/>
<br/>HEALTH MAINTENANCE~ <br/>
Screenings:
<ul><li>Colonoscopy on 11/2019</li><li>Dexascan on [REDACTED]</li><li>Mammogram - Screening (bilateral) on [REDACTED]</li><li>Pap Smear on 2022</li><li>Pelvic Exam on 2022</li></ul>
<br/>
Immunizations:
<ul><li>Colonoscopy (11/2019)</li></ul>
<br/>
Smoking Status: Smoking Tobacco : Former smoker, pack years: 15, stopped smoking: 11/2019; Smokeless Tobacco : none found; Vaping : none found<br/>


<br/>
<br/>REVIEW OF SYSTEMS~ <br/>
10 point review of systems was completed and is negative unless otherwise stated above HPI.
<br/>
<br/>
<br/>VITALS AND PERFORMANCE STATUS~ <br/>
Blood pressure: 120/76, Sitting, R arm, Regular, Pulse: 89, Temperature: 98.2 F, Respirations: 16, O2 sat: 98%, At Rest, Room Air, Pain Scale: 0, Height: 57.5 in, Weight: 99.6 lb, BSA: 1.35, BMI: 21.18 kg/m2<br/>
Karnofsky: 100% Normal, no complaints, no evidence of disease. (Date: [REDACTED])<br/>
<br/>



<br/>PHYSICAL EXAMINATION~ 

<br/>
<br/>Constitutional: Well appearing and in no acute distress.<br/>
General: No acute distress, alert and oriented x3.<br/>
HEENT: Oropharynx clear, mucous membranes moist.<br/>
Cardiovascular: Regular rate and rhythm, no rubs or gallops.<br/>
Respiratory: Clear to auscultation bilaterally, normal respiratory excursion.<br/>
Breasts: Left breast: [REDACTED].  Surgical scar healed.  No palpable chest wall masses, no skin changes, no axillary lymphadenopathy.  Right: Amastia.  Surgical scar healed.  No palpable chest wall masses, no skin changes, no axillary lymphadenopathy.<br/>
Gastrointestinal:  Soft, nontender, nondistended, normoactive bowel sounds, no guarding or rebound.<br/>
Lymphatics: No cervical, axillary, supraclavicular or infraclavicular lymphadenopathy.<br/>
Extremities: No cyanosis, clubbing or edema.<br/>
Neurology: Non-focal, moves all extremities.<br/>

<br/>
<br/>
<br/>
<br/>CURRENT MEDICATIONS~ <br/>

<ul><li>Letrozole Oral 2.5 mg tablet</li><li>Letrozole 2.5 mg tablet</li><li>Acetaminophen Oral ER Tab 650 mg tablet extended release</li><li>Turmeric (Curcumin) Oral</li><li>Cholecalciferol Oral 10 mcg (400 unit) tablet</li><li>Multivitamins Oral Tablet</li></ul>
<br/>
<br/>
<br/>ALLERGIES &amp; ADVERSE REACTIONS~ <br/>

<ul><li>Ascorbic Acid (Vitamin C)</li><li>Centrum</li><li>Iodine Containing Multivitamin</li><li>Iron Analogues</li></ul>
<br/>
<br/>
<br/>PROBLEM LIST~ <br/>

<ul><li>Primary malignant neoplasm of female breast (disorder)</li><li>Cancer antigen 27-29 above reference range (finding)</li><li>Estrogen receptor positive status [ER+]</li><li>Family history of malignant neoplasm of lung (situation)</li><li>Long-term current use of aromatase inhibitor (situation)</li><li>Lymphadenopathy (disorder)</li><li>Other specified anemias</li><li>Other specified disorders of bone density and structure, other site</li><li>Vitamin D deficiency (disorder)</li></ul>
<br/>



<br/>ASSESSMENT~ <br/>
<ol><li>Breast cancer, IDC with DCIS component, right, pT2 pN0 M0, diagnosed 10/2019, ER/PR positive, HER-2 negative, Oncotype DX score 21, s/p bilateral mastectomy.
	<ol><li>Adjuvant endocrine therapy with letrozole started [REDACTED]</li><li>Elevated CA 27–29</li><li>PET CT scan [REDACTED]: Indeterminate right axillary lymphadenopathy</li><li>Ultrasound-guided right axillary biopsy [REDACTED]: Negative for malignancy</li><li>PET CT scan [REDACTED]: Negative malignancy.  Resolved right axillary lymph node uptake (reactive lymph)</li></ol>
	</li><li>Osteopenia per DEXA scan 2/2020</li><li>Uterine fibroid</li></ol>
<br/>
<br/>PLANS~ <br/>
<ol><li>Clinical exam unremarkable.  Physical exam unremarkable patient denies any concerning symptoms for recurrent disease.  Laboratory studies were reviewed with patient, cancer marker continues to fluctuate but within normal limits, 37.6 at this time.  She continues to tolerate letrozole without any adverse side effects.  She is overdue for her DEXA scan, we will order for stat scan at this time.  We will continue to monitor and follow-up [REDACTED].<br/>
	</li><li>Treatment and supportive care
	<ol><li>Continue adjuvant endocrine therapy with letrozole to complete a total of 10 years (end date 1/2030). A refill was sent to her pharmacy [REDACTED].</li><li>Continue vitamin D 2000 IU daily</li></ol>
	</li><li>Diagnostic imaging
	<ol><li>Breast imaging not applicable (bilateral mastectomy)</li><li>DEXA scan every 2 years, overdue.  Ordered stat. <br/>
		</li></ol>
	</li><li>Labs on follow up
	<ol><li>CA 27-29, CBC w/ auto diff, CMP, vitamin D. (Prior to next visit)</li></ol>
	</li><li>Age- appropriate cancer screening reviewed - colonoscopy 11/2019</li><li>Referrals and follow-up
	<ol><li>[REDACTED] (PCP)</li><li>[REDACTED] (breast surgeon)</li><li>[REDACTED] (GYN)</li></ol>
	</li><li>RTC [REDACTED] and/or earlier if clinically indicated based on patient's symptoms (instructions given to patient).</li><li>After discussion of stated plans, patient verbalized understanding and agreement.  Answered all questions to her satisfaction.  Recommendations are within the confines of NCCN guidelines for breast cancer.  </li></ol>
 <br/>
<br/>
Greater than 50% of the time was spent on counseling and coordinating the patient's care. <br/>
<br/>
<br/>


<br/>NEW ORDERS~ <br/>
Labs:
<ul><li>[REDACTED], [REDACTED] 27-29 panel, Perform Date: Prior to Next Visit</li><li>[REDACTED], CBC w/ auto diff, Perform Date: Prior to Next Visit</li><li>[REDACTED], CMP, Perform Date: Prior to Next Visit</li><li>[REDACTED], Vitamin D, 25-OH, D3 panel, Perform Date: Prior to Next Visit</li></ul>
<br/>
Services:
<ul><li>[REDACTED], RTC MD, Perform Date: 6 Months</li></ul>
<br/>


<br/>Imaging:
<ul><li>[REDACTED], DEXA scan, Instructions: Scan overdue, stat order, Perform Date: STAT</li></ul>
<br/>
Prescriptions:
<ul><li>Letrozole 2.5 mg tablet take one tablet by mouth daily Dispense: 90 Tablet Refills: 0 Allow Substitution To: WALGREENS DRUG STORE #05479, [REDACTED] 891834428 Ph: 7026177895 From: [REDACTED], MSN,FNP,BSN,RN, DEA: [REDACTED] [REDACTED][REDACTED][REDACTED] Ph: [REDACTED]</li></ul>
<br/>


<br/>.<br/>
Discussed all treatments and any medications ordered with the patient and/or family.  Risks, benefits, alternatives, and complications were discussed in detail. Disclosed the possibility of severe or life-threatening side effects from medications/treatments - to include allergy, severe/permanent organ damage, death. All questions were answered. Instructions on proper usage of medications prescribed were given. Pt and family expressed understanding of the aforementioned information, and provided verbal agreement with the plan, as outlined above and as reflected in orders.<br/>
<br/>


<br/>[REDACTED], MSN, FNP, BSN, RN<br/>
<br/>


<br/>Send copy of note to:    <br/>
<br/>
<br/>
<br/>

<br/>Electronically signed by [REDACTED] MSN,FNP,BSN,RN [REDACTED] 13:23 PDT 
		        </p>
		      </li><li>
		        Nurse Note for: [REDACTED]: 
		        <p>
		        		Comprehensive Cancer Center of [REDACTED]<br/>Nurse Note<br/>Print Location: Unknown<br/>Date/Time Printed: [REDACTED] 11:31 ([REDACTED]/Los_Angeles)<br/>Patient: [REDACTED], MAY     Sex: Female      DOB: [REDACTED]      MRN:  [REDACTED]<br/>Date of Service: [REDACTED]<br/>Allergies :<br/>Iron Analogues, Iodine Containing Multivitamin, Centrum, Ascorbic Acid (Vitamin C)<br/>Patient Assessment :<br/>IV Access/Lab Draw :<br/>IV Access-Lab Draw Only - Peripheral vein (venipuncture), Needle Size-21 Gauge, Access Site-Right Arm, Lab Drawn-Yes, Tube Color-Lavender,SST, Comments-1 SST, 1 LAV  <br/>Entered By [REDACTED] Lab Assistant on 10:24<br/> 
		        </p>
		      </li><li>
		        Nurse Note for: [REDACTED]: 
		        <p>
		        		Comprehensive Cancer Center of [REDACTED]<br/>Nurse Note<br/>Print Location: Unknown<br/>Date/Time Printed: [REDACTED] 11:31 ([REDACTED]/Los_Angeles)<br/>Patient: [REDACTED], MAY     Sex: Female      DOB: [REDACTED]      MRN:  [REDACTED]<br/>Date of Service: [REDACTED]<br/>Allergies :<br/>Iron Analogues, Iodine Containing Multivitamin, Centrum, Ascorbic Acid (Vitamin C)<br/>Vital Signs :<br/>Time: 15:38. Weight: 95 lb (43.09 kg). Height: 57.5 in (146.05 cm). BMI: 20.2 (kg/m2) . BSA: 1.32 (m2) . Temperature: 98 (F)  forehead. Pulse: 72 (/min)  sitting. Respirations: 18 (/min) . Blood pressure: 102/68 (mm Hg) right arm Regular. Pain Scale: 0. O2 Saturation: 96 (%)  at rest.  Entered by [REDACTED] MA Sr [REDACTED] 15:38<br/>Incident To Details :<br/>Incident to physician is present and immediately available to furnish assistance and provide supervision throughout the treatment.<br/>Entered By [REDACTED] MA Sr on 15:36<br/>Patient Assessment :<br/>Negative results Assessment :<br/>Denies Pain -0-No pain. <br/>Discharge Note :<br/>Comments-Therapy completed without adverse event, Afebrile, Dr. order to continue w/ treatment, Dressing intact, Injection cap(s) in place, Discharged from clinic, Stable, No new complaints, No Weakness, No c/o dizziness, Plan for next patient visit confirmed, Patient instructed to call office with any questions or problems, Accompanied By-Self, Discharge-Ambulatory, Discharge Time-11/01/2023 11:28<br/>Entered By [REDACTED] MA Sr on 15:37<br/>Medication Administration :<br/>Incident to: [REDACTED], MD<br/>Denosumab (Prolia) Q6Month<br/>Immunotherapy<br/>Denosumab Subcutaneous (60 mg/mL - Prolia), 60 mg/mL syringe, 60 mg subcutaneously once, Instructions: Administer SQ injection in the upper arm, upper thigh or abdomen., Allow Substitution<br/>     GIVEN: 60 mg<br/>     Pharmacy plan: Dose Form Description: 60 mg/mL syringe Dispense/Waste: 60/0 mg<br/>     Pharmacy dispense: NDC: 55513071001 Dispense/Waste: 60/0 mg<br/>     Given Dose/Discard: 60/0 mg<br/>     Admin Details: Injection Location: Right-[REDACTED]<br/>     Time: 11:25<br/>     Double Checked By: [REDACTED] on [REDACTED] 11:30 and [REDACTED] MA Sr on [REDACTED] 15:37<br/> 
		        </p>
		      </li><li>
		        Nurse Note for: [REDACTED]: 
		        <p>
		        		Comprehensive Cancer Center of [REDACTED]<br/>Nurse Note<br/>Print Location: Unknown<br/>Date/Time Printed: [REDACTED] 11:31 ([REDACTED]/Los_Angeles)<br/>Patient: [REDACTED], MAY     Sex: Female      DOB: [REDACTED]      MRN:  [REDACTED]<br/>Date of Service: [REDACTED]<br/>Allergies :<br/>Iron Analogues, Iodine Containing Multivitamin, Centrum, Ascorbic Acid (Vitamin C)<br/>Patient Assessment :<br/>IV Access/Lab Draw :<br/>IV Access-Lab Draw Only - Peripheral vein (venipuncture), Needle Size-21 Gauge, Access Site-Left Arm, Lab Drawn-Yes, Tube Color-SST, Comments-1 SST, 1 LAV  <br/>Entered By [REDACTED] Lab Assistant on 09:50<br/> 
		        </p>
		      </li><li>
		        Nurse Note for: [REDACTED]: 
		        <p>
		        		Comprehensive Cancer Center of [REDACTED]<br/>Nurse Note<br/>Print Location: Unknown<br/>Date/Time Printed: [REDACTED] 11:31 ([REDACTED]/Los_Angeles)<br/>Patient: [REDACTED], MAY     Sex: Female      DOB: [REDACTED]      MRN:  [REDACTED]<br/>Date of Service: [REDACTED]<br/>Allergies :<br/>Iron Analogues, Iodine Containing Multivitamin, Centrum, Ascorbic Acid (Vitamin C)<br/>Patient Assessment :<br/>IV Access/Lab Draw :<br/>IV Access-Lab Draw Only - Peripheral vein (venipuncture), Needle Size-21 Gauge, Access Site-Right Arm, Lab Drawn-Yes, Tube Color-Lavender,SST, <br/>Entered By [REDACTED] Lab Assistant on 14:04<br/> 
		        </p>
		      </li></ul>
</div><br/><br/>
</body></html>